Multivalent Pneumococcal Conjugate Vaccine(CanSino Biologics)

N/A

Report date: 2025/11/12 16:25:22

Base Information

Drug NameMultivalent Pneumococcal Conjugate Vaccine(CanSino Biologics)
Drug Alias NameCS-2028
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Cansino Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Cansino Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A